1,123 results on '"Velkoska, E"'
Search Results
2. Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial.
3. IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial.
4. CSL112 (apolipoprotein A-I [human]) reduces the elevation in neutrophil-lymphocyte ratio (NLR) induced by acute myocardial infarction
5. CSL112 (Apolipoprotein A-I [Human]) Reduces the Elevation in Neutrophil-to-Lymphocyte Ratio Induced by Acute Myocardial Infarction.
6. CSL112 Infusion Rapidly Increases APOA1 Exchange Rate via Specific Serum Amyloid-Poor HDL Subpopulations When Administered to Patients Post-Myocardial Infarction.
7. CSL112 (human apolipoprotein A-I) infusion rapidly increases apoA-I exchange rate (AER) when administered to patients post myocardial infarction
8. Alteration of the renin-angiotensin system in the circulation, terminal ileum and colon in patients with inflammatory bowel disease: a potential novel therapeutic target
9. A method for detection of anti-drug antibodies to a biotherapeutic (CSL112) with endogenous counterpart (apolipoprotein A-I) using a novel sample pre-treatment electrochemiluminescence assay.
10. Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7/MAS-1-dependent pathways
11. Angiotensin converting enzyme 2 (ACE2) activity in fetal calf serum: implications for cell culture research
12. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition
13. Undernutrition during suckling in rats elevates plasma adiponectin and its receptor in skeletal muscle regardless of diet composition: a protective effect?
14. Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression
15. Leptin reduces food intake but does not alter weight regain following food deprivation in the rat†
16. Antiatherosclerotic Effects of CSL112 Mediated by Enhanced Cholesterol Efflux Capacity.
17. Left ventricular hypertrophy in experimental chronic kidney disease is associated with reduced expression of cardiac Kruppel-like factor 15
18. An exploratory analysis of comparative plasma metabolomic and lipidomic profiling in salt-sensitive and salt-resistant individuals from The Dietary Approaches to Stop Hypertension Sodium Trial.
19. Genetic Variation in Kruppel like Factor 15 Is Associated with Left Ventricular Hypertrophy in Patients with Type 2 Diabetes: Discovery and Replication Cohorts
20. P6340Plasma ACE2 activity is a novel and independent predictor of all-cause mortality in patients with aortic stenosis
21. P2618Increased plasma ACE2 activity is a marker of subclinical LV systolic dysfunction in patients with aortic stenosis
22. Increased Plasma ACE2 Activity is a Marker of Subclinical LV Systolic Dysfunction in Patients With Aortic Stenosis
23. Diminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease
24. The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation
25. Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?
26. Highlights from the International Society of Hypertension's New Investigators Network during 2019.
27. Kruppel Like Factor 15 Expression is Associated with Cardiac Hypertrophy in an Experimental Model of Kidney Disease
28. The ACE2 Activator Diminazene Improves Cardiac Structure and Function in an Experimental Model of Kidney Disease
29. Short-Term Treatment with Diminazene Aceturate Ameliorates the Reduction in Kidney ACE2 Activity in Rats with Subtotal Nephrectomy
30. Circulating receptor for advanced glycation end products (RAGE) is a risk factor for developing heart failure
31. From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension
32. Plasma ACE2 Activity is a Novel and Independent Predictor of All-Cause Mortality in Patients with Aortic Stenosis
33. Emerging markers in cardiovascular disease: Where does angiotensin-converting enzyme 2 fit in?
34. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition
35. The CTGF gene-945 G/C polymorphism is not associated with cardiac or kidney complications in subjects with type 2 diabetes
36. Mechanisms behind early life nutrition and adult disease outcome
37. Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition
38. Left ventricular hypertrophy in experimental chronic kidney disease is associated with reduced expression of cardiac Kruppel-like factor 15.
39. Undernutrition during suckling in rats elevates plasma adiponectin and its receptor in skeletal muscle regardless of diet composition : a protective effect?
40. P096 Circulating components of the alternative renin–angiotensin system are upregulated in patients with inflammatory bowel disease
41. Does Heparin Modulate Circulating Levels of Soluble Receptor for Advanced Glycation End Products in Patients Undergoing Percutaneous Coronary Intervention (PCI)?
42. A Novel Relationship Between Circulating RAGE and Pulmonary Hypertension
43. Are Soluble Receptors of Advanced Glycation End Products Associated With Pre-CLINICAL Diastolic Dysfunction in Patients With Diabetes?
44. Do Soluble Receptors of Advanced Glycation end Products Correlate with Invasively Determined Left Ventricular Filling Pressure?
45. Unaltered TNF-alpha production by macrophages and monocytes in diet-induced obesity in the rat.
46. Association of ACE2 Genetic Variants With Blood Pressure, Left Ventricular Mass, and Cardiac Function in Caucasians With Type 2 Diabetes
47. Are Advanced Glycation End Products (AGEs) Associated with Elevated Filling Pressures Diabetes?
48. Angiotensin Converting Enzyme (ACE) 2: A Novel Marker of Coronary Artery Disease (CAD) in Man
49. Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the rat
50. Effect of diminazene on cardiac hypertrophy through mitophagy in rat models with hyperthyroidism induced by levothyroxine.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.